This test is most useful if any of these apply to you.
If you have ever wondered whether your cellular energy systems and kidneys are working as smoothly as they should, urinary succinic acid offers an unusual window. It is a small molecule your cells make every minute as they generate energy, and the amount that spills into your urine reflects how well that machinery is running.
This is not a routine number on a standard panel, and that is precisely the point. Patterns in urinary succinic acid have been linked to early kidney trouble in diabetes, mitochondrial stress in chronic kidney disease, and shifts seen in Parkinson's disease and some hormone-driven conditions. None of these show up on a basic chemistry panel.
Succinic acid (succinate) is a step in the citric acid cycle, the recycling loop your cells use to turn food into usable energy. It is produced inside the energy-generating compartments of your cells (called mitochondria) and is also made by certain bacteria in your gut. Because almost every cell in your body uses this cycle, succinic acid is not tied to one organ.
When this cycle is running smoothly, succinate stays mostly inside cells and gets processed into the next step. When the cycle is stressed, when mitochondria are struggling, or when the kidneys handle this molecule differently, more of it spills into urine. That is the signal this test picks up.
In a study of 235 adults with type 2 diabetes, higher urinary succinate was independently associated with diabetic kidney disease and with protein leaking into the urine (albuminuria). The link held up after accounting for other risk factors, and higher levels also tracked with a faster decline in kidney function over time.
Larger studies of the same population have found that, among citric acid cycle molecules in urine, fumarate and citrate tend to be the strongest independent predictors of chronic kidney disease progression in type 2 diabetes, with succinate part of a broader pattern rather than the single best predictor. This is why succinate is most useful when interpreted alongside other markers.
What this means for you: if you have type 2 diabetes, a rising urinary succinate trend can flag kidney stress earlier than waiting for creatinine or estimated filtration rate to move noticeably. It is a complementary signal, not a replacement for standard kidney labs.
In people with chronic kidney disease who do not have diabetes, urinary succinate and other citric acid cycle molecules were reduced by 40 to 68 percent compared with healthier kidneys. The kidney tissue itself also showed less expression of the genes that drive these reactions. The pattern fits the idea that chronic kidney disease is, in part, a disease of struggling mitochondria.
You may notice these two findings seem to point in opposite directions: high urinary succinate in diabetic kidney disease, low urinary succinate in non-diabetic chronic kidney disease. This is not a contradiction. Urinary succinate is a phenotype indicator, not a simple good number or bad number marker. In early diabetic kidney injury, kidney cells appear to release more succinate; in advanced non-diabetic kidney disease, the citric acid cycle is so depressed that less is produced overall. The direction may also depend on the stage of kidney disease, not only its cause. The clinical meaning depends on the setting, which is why a single reading without context is hard to interpret and why pairing this test with kidney function markers matters.
In a study of 56 people with clear cell kidney cancer, the change in urinary succinic acid before and after surgery was one of five molecules that, together, predicted whether the cancer would come back, with an area under the curve of 0.894, sensitivity near 89 percent, and specificity near 88 percent. Succinate did not work alone; it contributed to a panel.
A pilot study of 40 people found that urinary succinic acid was significantly higher in those with Parkinson's disease than in healthy controls. A separate, larger study of 100 people with Parkinson's disease and 50 controls reported the same direction of finding, with urinary succinate also correlating with motor severity scores. This is early research that fits a consistent pattern across studies, not a diagnostic test for Parkinson's.
In a study of 37 women, urinary succinic acid was markedly lower in those with polycystic ovary syndrome than in healthy controls, alongside several other shifted metabolites. In epithelial ovarian cancer, urinary succinic acid shifted back toward normal after surgical removal of the tumor, suggesting it changes with disease burden as part of a broader urinary metabolite panel.
Urinary succinic acid is a research-grade marker. There are no universally agreed cutpoints, and a single value tells you very little. What is far more useful is your own trajectory. No clinical guideline has established an optimal retesting interval, so most expert recommendations, including the ones in this article, are based on practical experience rather than formal evidence. A common practical approach is a baseline now, a follow-up in three to six months if you are making changes, and at least annual tracking after that. Establishing your personal pattern lets you see whether things are drifting in either direction long before any threshold becomes relevant.
This is also why pairing with related tests matters. Urinary succinate alone is rarely diagnostic. In context, alongside kidney function markers, glucose control, and a urinalysis, the trend becomes meaningful.
Urinary metabolites can shift for reasons that have nothing to do with disease. The most important things to know:
If your urinary succinic acid sits outside what looks typical for you, the next step is not panic; it is workup in context. Pair this number with a comprehensive metabolic panel, a urinalysis with urine albumin to creatinine ratio, and HbA1c if diabetes is on the table. If kidney markers are also drifting, a nephrologist consultation makes sense. If the broader urinary organic acid profile shows multiple shifts together, that pattern is more informative than succinate alone.
For people without diabetes whose succinate is unexpectedly low alongside other depressed citric acid cycle molecules, the conversation shifts toward mitochondrial health and overall kidney function. For people with diabetes whose succinate is climbing, the priority is tighter management of the upstream drivers: glucose, blood pressure, and weight.
People with type 2 diabetes who want an earlier warning system for kidney stress, people with a family history of chronic kidney disease, and people working through a broader metabolomic workup tend to get the most signal from this test. For someone with no risk factors and normal kidney and glucose labs, the value is mainly establishing a personal baseline to compare against later.
Succinic Acid is best interpreted alongside these tests.
Succinic Acid is included in these pre-built panels.